X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (232) 232
Conference Proceeding (49) 49
Publication (37) 37
Patent (9) 9
Book Review (7) 7
Book Chapter (3) 3
Dissertation (2) 2
Newspaper Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (96) 96
index medicus (95) 95
humans (76) 76
male (48) 48
middle aged (34) 34
female (33) 33
aged (32) 32
cancer (30) 30
animals (27) 27
article (26) 26
kidney neoplasms - pathology (23) 23
carcinoma, renal cell - drug therapy (21) 21
metastasis (21) 21
care and treatment (20) 20
kidney neoplasms - drug therapy (20) 20
adult (18) 18
aged, 80 and over (17) 17
carcinoma, renal cell - pathology (16) 16
cell line, tumor (16) 16
mice (16) 16
sunitinib (16) 16
analysis (15) 15
treatment outcome (15) 15
carcinoma, renal cell (14) 14
disease-free survival (14) 14
immunotherapy (14) 14
renal cell carcinoma (14) 14
survival (14) 14
therapy (14) 14
antineoplastic agents - therapeutic use (12) 12
everolimus (12) 12
hematology, oncology and palliative medicine (12) 12
kidney cancer (12) 12
neoplasm metastasis (12) 12
angiogenesis (11) 11
carcinoma, renal cell - mortality (11) 11
carcinoma, renal cell - secondary (11) 11
efficacy (11) 11
expression (11) 11
kidney neoplasms - mortality (11) 11
melanoma (11) 11
nivolumab (10) 10
prognosis (10) 10
sorafenib (10) 10
tumors (10) 10
urology (10) 10
disease progression (9) 9
immunology (9) 9
open-label (9) 9
prostate cancer (9) 9
research (9) 9
xenograft model antitumor assays (9) 9
antineoplastic agents (8) 8
ipilimumab (8) 8
metastatic renal cell carcinoma (8) 8
outcome (8) 8
radiology, nuclear medicine & medical imaging (8) 8
retrospective studies (8) 8
urology & nephrology (8) 8
vascular endothelial growth factor (8) 8
antibodies, monoclonal - administration & dosage (7) 7
antineoplastic agents - pharmacology (7) 7
apoptosis (7) 7
clinical trials (7) 7
dose-response relationship, drug (7) 7
endothelial growth-factor (7) 7
environmental sciences (7) 7
guidelines (7) 7
interferon-alpha (7) 7
patient outcomes (7) 7
patients (7) 7
pazopanib (7) 7
survival rate (7) 7
targeted therapy (7) 7
angiogenesis inhibitors - pharmacology (6) 6
antibodies, monoclonal - adverse effects (6) 6
antimitotic agents (6) 6
carcinoma, renal cell - therapy (6) 6
cell proliferation - drug effects (6) 6
chemotherapy (6) 6
clear cell-type renal cell carcinoma (6) 6
indoles - therapeutic use (6) 6
mice, nude (6) 6
neuroimaging (6) 6
neurosciences (6) 6
pet imaging (6) 6
prostatic neoplasms - drug therapy (6) 6
pyrroles - therapeutic use (6) 6
risk factors (6) 6
solid tumors (6) 6
studies (6) 6
survival analysis (6) 6
t-cells (6) 6
time factors (6) 6
abridged index medicus (5) 5
activation (5) 5
animal reproduction (5) 5
antibodies, monoclonal - therapeutic use (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
brain (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 7, pp. 917 - 927
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 86, Issue 2, pp. 343 - 349
Purpose Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults, and radiation is one of the main treatment modalities. However, cure... 
Radiology | Hematology, Oncology and Palliative Medicine | CTLA-4 BLOCKADE | IMMUNITY | MELANOMA | ONCOLOGY | METASTASES | INCREASES | ANTIBODY | EXPRESSION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | T-CELLS | IPILIMUMAB | TEMOZOLOMIDE | Immunotherapy - methods | Spleen - immunology | Combined Modality Therapy - mortality | T-Lymphocytes, Regulatory - immunology | Brain Neoplasms - immunology | Time Factors | T-Lymphocytes, Regulatory - cytology | Female | Brain Neoplasms - mortality | Neck | Radiosurgery - methods | T-Lymphocytes, Cytotoxic - immunology | Antigens, Neoplasm - immunology | Mice, Inbred C57BL | Lymph Nodes - immunology | Xenograft Model Antitumor Assays - methods | Glioblastoma - therapy | Immunotherapy - mortality | Animals | B7-H1 Antigen - antagonists & inhibitors | Glioblastoma - immunology | Brain Neoplasms - therapy | Survival Analysis | Cell Line, Tumor | Combined Modality Therapy - methods | Mice | Radiosurgery - mortality | Brain - immunology | Glioblastoma - mortality | T-Lymphocytes, Cytotoxic - cytology | Sects | T cells | Gliomas | Nuclear radiation | Immunotherapy | Radiosurgery | Index Medicus | ANTIBODIES | GLIOMAS | SURGERY | LYMPH NODES | ANTIGENS | DEATH | LUCIFERASE | INTERFERON | SPLEEN | INHIBITION | LIGANDS | IMMUNOTHERAPY | RADIOLOGY AND NUCLEAR MEDICINE | MICE | RADIOTHERAPY | RADIOPROTECTIVE SUBSTANCES | RECEPTORS | BRAIN
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2015, Volume 373, Issue 19, pp. 1803 - 1813
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2018, Volume 378, Issue 14, pp. 1277 - 1290
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2015, Volume 373, Issue 19, pp. 1814 - 1823
Journal Article
Animal Behaviour, ISSN 0003-3472, 2008, Volume 76, Issue 4, pp. 1403 - 1410
Journal Article
European Urology, ISSN 0302-2838, 01/2017, Volume 71, Issue 1, pp. 145 - 146
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 12/2008, Volume 105, Issue 50, pp. 19579 - 19586
Journal Article
Journal Article